Lucentis and Stool softener needs - a phase IV clinical study of FDA data

Summary:

Stool softener needs is reported as a side effect among people who take Lucentis (ranibizumab), especially for people who are female, 60+ old, have been taking the drug for 1 - 2 years also take Coumadin, and have High blood pressure.

The phase IV clinical study analyzes which people have Stool softener needs when taking Lucentis. It is created by eHealthMe based on reports of 25,577 people who have side effects when taking Lucentis from the FDA, and is updated regularly.

What is Lucentis?

Lucentis has active ingredients of ranibizumab. It is often used in macular degeneration. eHealthMe is studying from 25,647 Lucentis users. Check the latest studies of Lucentis.

What is Stool softener needs?

Stool softener needs is found to be associated with 3,891 drugs and 4,762 conditions by eHealthMe. Check the latest studies of Stool softener needs.

On Apr, 06, 2026

25,577 people reported to have side effects when taking Lucentis.
Among them, 52 people (0.2%) have Stool softener needs.

Could Lucentis cause Stool softener needs?

Among these 52 people:

How long have people been on Lucentis when they have Stool softener needs? *

What is the gender of people who have Stool softener needs when taking Lucentis? *

female: 69.57 %
male: 30.43 %

What is the age of people who have Stool softener needs when taking Lucentis? *

What are other drugs people take besides Lucentis? *

What are other side effects people have besides Stool softener needs? *

Fatigue (feeling of tiredness): 16 people, 30.77%
Weight Decreased: 14 people, 26.92%
Dizziness: 14 people, 26.92%
Nausea (feeling of having an urge to vomit): 12 people, 23.08%
Weakness: 11 people, 21.15%
Diarrhea: 10 people, 19.23%
Visual Impairment: 10 people, 19.23%
Dyspnea (difficult or laboured breathing): 10 people, 19.23%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 8 people, 15.38%
Malaise (a feeling of general discomfort or uneasiness): 7 people, 13.46%

What are the existing conditions these people have? *

High Blood Pressure: 9 people, 17.31%
Macular Oedema (fluid and protein deposits collect on or under the macula of the eye (a yellow central area of the retina) and causes it to thicken): 4 people, 7.69%
Pain: 4 people, 7.69%
Diabetic Retinal Oedema (excessive build-up of fluid in the retina due to diabetes): 4 people, 7.69%
Diabetic Retinopathy (damage to the retina caused by complications of diabetes): 4 people, 7.69%
Osteoporosis (bones weak and more likely to break): 4 people, 7.69%
Age-Related Macular Degeneration: 4 people, 7.69%
Multiple Myeloma (cancer of the plasma cells): 3 people, 5.77%
Muscle Spasms (muscle contraction): 3 people, 5.77%
Hypercalcaemia (elevated calcium (ca+) level in the blood): 3 people, 5.77%

* Approximation only. Some reports may have incomplete information.

Do you take Lucentis and have Stool softener needs?

- Check whether Stool softener needs is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lucentis:

Lucentis (25,647 reports)

Browse all side effects of Lucentis:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Stool softener needs:

Stool softener needs (3,891 drugs)

Browse all the conditions that are associated with Stool softener needs:

Stool softener needs (4,762 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ranibizumab (the active ingredients of Lucentis) and Lucentis (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.